HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Supportive therapy with xenogenous peptides in patients with metastatic breast cancer undergoing aggressive chemotherapy (modified AC-protocol): a prospective, randomized double-blind study].

AuthorsO F Lange
JournalOnkologie (Onkologie) Vol. 10 Issue 3 Suppl Pg. 40-3 (Jun 1987) ISSN: 0378-584X [Print] Switzerland
Vernacular TitleSupportive Therapie mit xenogenen Peptiden bei Patienten mit metastasiertem Mammakarzinom unter aggressiver Chemotherapie (modifiziertes AC-Schema): Eine prospektive, randomisierte Doppelblindstudie.
PMID3309762 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Peptides
  • Doxorubicin
  • Cyclophosphamide
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Breast Neoplasms (drug therapy, therapy)
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Cyclophosphamide (therapeutic use)
  • Double-Blind Method
  • Doxorubicin (therapeutic use)
  • Female
  • Humans
  • Immunotherapy
  • Peptides (therapeutic use)
  • Prospective Studies
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: